Evidence map›Paper›PMID 28406749›Full record

ArticleNucleus (Austin, Tex.)2017

Nucleosome repositioning during differentiation of a human myeloid leukemia cell line.

Vladimir B Teif, Jan-Philipp Mallm, Tanvi Sharma, David B Mark Welch, Karsten Rippe, Roland Eils, Jörg Langowski, Ada L Olins, Donald E Olins

Open access · goldAbstract read
In one paragraph

Article in Nucleus (Austin, Tex.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Study of Dispersed Repeats in theInternational journal of molecular sciences · 2024
    Article
  6. Article
  7. Neutrophil nucleus: shaping the past and the future.Journal of leukocyte biology · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Defining the epichromatin epitope.Nucleus (Austin, Tex.) · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Vladimir B Teifa School of Biological Sciences , University of Essex, Wivenhoe Park , Colchester , UK.
Jan-Philipp Mallmb German Cancer Research Center (DKFZ) , Heidelberg , Germany.
Tanvi Sharmaa School of Biological Sciences , University of Essex, Wivenhoe Park , Colchester , UK.
David B Mark Welchc Josephine Bay Paul Center for Comparative Molecular Biology and Evolution , Marine Biological Laboratory , Woods Hole , MA , USA.
Karsten Rippeb German Cancer Research Center (DKFZ) , Heidelberg , Germany.
Roland Eilsb German Cancer Research Center (DKFZ) , Heidelberg , Germany.
Jörg Langowskib German Cancer Research Center (DKFZ) , Heidelberg , Germany.
Ada L Olinsd Department of Pharmaceutical Sciences , College of Pharmacy, University of New England , Portland , ME , USA.
Donald E Olinsd Department of Pharmaceutical Sciences , College of Pharmacy, University of New England , Portland , ME , USA.
German Cancer Research Center · DENew England College · USUniversity of Essex · GBMarine Biological Laboratory · US

Funding

Wellcome Trust 200733/Z/16/Z
6 · The paper itself

Abstract

Cell differentiation is associated with changes in chromatin organization and gene expression. In this study, we examine chromatin structure following differentiation of the human myeloid leukemia cell line (HL-60/S4) into granulocytes with retinoic acid (RA) or into macrophage with phorbol ester (TPA). We performed ChIP-seq of histone H3 and its modifications, analyzing changes in nucleosome occupancy, nucleosome repeat length, eu-/heterochromatin redistribution and properties of epichromatin (surface chromatin adjacent to the nuclear envelope). Nucleosome positions changed genome-wide, exhibiting a specific class of alterations involving nucleosome loss in extended (∼1kb) regions, pronounced in enhancers and promoters. Genes that lost nucleosomes at their promoters showed a tendency to be upregulated. On the other hand, nucleosome gain did not show simple effects on transcript levels. The average genome-wide nucleosome repeat length (NRL) did not change significantly with differentiation. However, we detected an approximate 10 bp NRL decrease around the haematopoietic transcription factor (TF) PU.1 and the architectural protein CTCF, suggesting an effect on NRL proximal to TF binding sites. Nucleosome occupancy changed in regions associated with active promoters in differentiated cells, compared with untreated HL-60/S4 cells. Epichromatin regions revealed an increased GC content and high nucleosome density compared with surrounding chromatin. Epichromatin showed depletion of major histone modifications and revealed enrichment with PML body-associated genes. In general, chromatin changes during HL-60/S4 differentiation appeared to be more localized to regulatory regions, compared with genome-wide changes among diverse cell types studied elsewhere.

Indexed as

Cell DifferentiationCell Line, TumorHistonesHumansLeukemia, MyeloidNucleosomesPromoter Regions, GeneticHistonesNucleosomesCTCF: Epichromatinhistone modificationsnucleosome positioningnucleosome repeat lengthtranscription factor binding

Identifiers

PMID28406749
PMCPMC5403151
OpenAlexW2589898022

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.